An open, prospective, single centre study to assess the confidence, usability, preference and satisfaction on use of peak flow master in healthy volunteers and in subjects with mild Asthma or COPD.

Cipla Ltd0 sites30 target enrollmentTBD

Overview

Phase: Phase 4
Intervention: Not specified
Conditions: Not specified
Sponsor: Cipla Ltd
Enrollment: 30
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

4 years ago

Study Type

Observational

Investigators

Sponsor

Cipla Ltd

Eligibility Criteria

Inclusion Criteria

•1\.Subjects and healthy volunteers willing to sign informed consent
•2\.Subjects and healthy volunteers of 18 years and above
•3\.Subjects with or without a respiratory condition. Each subject with a respiratory condition (prior experience of using an device) should be matched as far as possible with an individual without a respiratory condition (device naÃ¯ve) with respect to the age, sex, literacy status etc
•4\.Subjects with mild Asthma or COPD or healthy volunteer.
•5\.Subjects who are only English speaking

Exclusion Criteria

•1\.Subjects already using Peak flow master prior to start of the study.
•2\.Subjects with co\-ordination problems like Parkinson?s disease, mental illness, tremors etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Phase 4

Study to assess the confidence, usability,preference and satisfaction on use of Zerostat spacer in healthy volunteersand in subjects with mild Asthma or COPD.Health Condition 1: null- Subjects with mild Asthma or COPD or healthy volunteer.

CTRI/2014/03/004448Cipla Ltd30

Completed

Phase 4

A clinical trial to assess the confidence, usability, preference and satisfaction on use of Baby Mask with valve from parents of children who are healthy or who have mild Asthma.

CTRI/2009/091/000958Cipla Ltd30

Completed

Phase 4

Study to assess the confidence, usability, preference and satisfaction on use of Zerostat-VT Spacer in healthy volunteers and in subjects with mild asthama or COPDHealth Condition 1: null- subjects with mild asthma or COPD

CTRI/2014/02/004432Cipla Ltd30

Completed

Phase 4

Study to assess the confidence, usability,preference and satisfaction on use of Zerostat-V spacer in healthy volunteersand in subjects with mild Asthma or COPD.Health Condition 1: null- Healthy volunteers and subjects with mild Asthma orCOPD.

CTRI/2014/03/004462Cipla Ltd30

Active, not recruiting

Phase 1

Open, prospective, single-center study evaluating the efficacy and safety of 0.05% ingénol mebutate (Picato® 500) in the treatment of basal cell carcinomaStudy PICABAS

EUCTR2017-004608-22-FRCHU de Nice28